07:58 AM EDT, 05/10/2019 (MT Newswires) -- MediPharm Labs Corp. ... a global player in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation,
---> announced Friday first quarter financial results for the three months ended March 31, 2019,
---> including revenue of $22 million,
---> a 115% increase over Q4 2018.
It said Q1 revenue
---> includes $7.6 million revenue for initial shipment of large private label cannabis oil contract with a large Licensed Producer.
MediPharm saw its stock jump more than 10% to 6.35 on Thursday, taking it closer to a 52 week high of 6.52.
Among other Q1 highlights,
---> it had a gross profit of $6.9 million and
---> gross margin 31%.
---> Adjusted EBITDA was $4.3 million,
---> a 102% increase over Q4 2018, while
---> Adjusted EBITDA margin was 20%.
Price: 6.35, Change: +0.60, Percent Change: +10.43
---> See new Friday High $6.70
07:58 AM EDT, 05/10/2019 (MT Newswires) -- MediPharm Labs Corp. ... a global player in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation,
---> announced Friday first quarter financial results for the three months ended March 31, 2019,
---> including revenue of $22 million,
---> a 115% increase over Q4 2018.
It said Q1 revenue
---> includes $7.6 million revenue for initial shipment of large private label cannabis oil contract with a large Licensed Producer.
MediPharm saw its stock jump more than 10% to 6.35 on Thursday, taking it closer to a 52 week high of 6.52.
Among other Q1 highlights,
---> it had a gross profit of $6.9 million and
---> gross margin 31%.
---> Adjusted EBITDA was $4.3 million,
---> a 102% increase over Q4 2018, while
---> Adjusted EBITDA margin was 20%.
Price: 6.35, Change: +0.60, Percent Change: +10.43
---> See new Friday High $6.70